Stereotactic and Sonographic Large-Core Biopsy of Nonpalpable Breast Lesions: Results of the Radiologic Diagnostic Oncology Group V Study

Academic Radiology

Volumn 11, Issue 3, 2004, Pages 293-308

  Fajardo, Laurie L ^a,h   Pisano, Etta D ^b   Caudry, Daryl J ^c   Gatsonis, Constantine A ^d   Berg, Wendie A ^e   Connolly, James ^c   Schnitt, Stuart ^c   Page, David L ^f   McNeil, Barbara J ^c,g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Breast cancer diagnosis; Breast core biopsy; Nonpalpable breast lesions; Stereotactic breast biopsy; Ultrasound guided breast biopsy

Indexed keywords

ADULT; AGED; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RADIOLOGIST; REVIEW; STEREOTAXIC SURGERY; ULTRASOUND;

EID: 1442330147     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)00510-5     Document Type: Article

References (60)

1. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997; 22:79-86.
2. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 16:1089-1096.
3. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993; 270:2444-2450.
4. National Cancer Institute Breast cancer (PDQ) screening Available at: www.cancer.gov/cancer_information/doc-pdq.aspx?version=provider&viewed= b906d.
5. Ciatto S, Cataliotti L, Distante V. Nonpalpable lesions detected with mammography: review of 512 consecutive cases. Radiology 1987; 165:99-102.
6. Hall FM, Storella JM, Silverstone DZ, Wyshak G. Nonpalpable breast lesions: recommendations for biopsy based on suspicion of carcinoma at mammography. Radiology 1988; 167:353-358.
7. Sickles EA, Ominsky SH, Sollitto RA, Galvin HB, Monticciolo DL. Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. Radiology 1990; 175:323-327.
8. Skinner MA, Swain M, Simmons R, McCarty KS Jr, Sullivan DC, Iglehart JD. Nonpalpable breast lesions at biopsy. A detailed analysis of radiographic features. Ann Surg 1988; 208:203-208.
9. Spivey GH, Perry BW, Clark VA, Coulson AH, Coulson WF. Predicting the risk of cancer at the time of breast biopsy. Am Surg 1982; 48:326-332.
10. Molloy M, Azarow K, Garcia VF, Daniel JR. Enhanced detection of preinvasive breast cancer: combined role of mammography and needle localization biopsy. J Surg Oncol 1989; 40:152-154.
11. Bassett LW, Liu TH, Giuliano AE, Gold RH. The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions. AJR Am J Roentgenol 1991; 157:21-24.
12. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3184 consecutive cases. Radiology 1991; 179:463-468.
13. Varas X, Leborgne F, Leborgne JH. Nonpalpable, probably benign lesions: role of follow-up mammography. Radiology 1992; 184:409-414.
14. Sickles EA. Nonpalpable, circumscribed, noncalcified solid breast masses: likelihood of malignancy based on lesion size and age of patient. Radiology 1994; 192:439-442.
15. Sickles EA. Findings at mammographic screening on only one standard projection: outcomes analysis. Radiology 1998; 208:471-475.
16. Vizcaino I, Gadea L, Andreo L, Salas D, Ruiz-Perales F, et al. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography. Radiology 2001; 219:475-483.
17. Helvie MA, Ikeda DM, Adler DD. Localization and needle aspiration of breast lesions: complications in 370 Cases. AJR Am J Roentgenol 1991; 157:711-714.
18. Cyrlak D. Induced costs of low-cost screening mammograpny. Radiology 1988; 168:661-663.
19. Parker SH, Lovin JD, Jobe WE, et al. Nonpalpable breast lesions: stereotactic automated large-core biopsies. Radiology 1991; 180:403-407.
20. Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology 1993; 188:453-455.
21. Gisvold JJ, Goellner JR, Grant CS, et al. Breast biopsy: a comparative study of stereotactically guided core and excisional biopsies. AJR Am J Roentgenol 1994; 162:815-820.
22. Parker SH, Burbank F, Jackman RJ, Aucreman CJ, Cardenosa G. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994; 193:359-364.
23. Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA. Stereotactic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994; 193:91-95.
24. Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology 1995; 194:379-381.
25. Liberman L, Fahs MC, Dershaw DD, et al. Impact of stereotactic core biopsy on cost of diagnosis. Radiology 1995; 195:633-637.
26. Nguyen M, McCombs MM, Ghandehad S, et al. An update on core needle biopsy for radiologically detected breast lesions. Cancer 1996; 78:2340-2345.
27. Brenner RJ, Fajardo LL, Fisher PR, et al. Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. AJR Am J Roentgenol 1996; 166:341-346.
28. Hillner BE, Bear HD, Fajardo LL. Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model. Acad Radiol 1996; 3:351-360.
29. Fajardo LL, DeAngelis GA. The role of stereotactic biopsy in abnormal mammograms. Surg Oncol Clin North Am 1997; 6:285-299.
30. Liberman L, Feng TL, Dershaw DD, Morris EA, Abramson AF. US-guided core breast biopsy: use and cost-effectiveness. Radiology 1998; 208:717-723.
31. Seoudi H, Mortier J, Basile R, Curletti E. Stereotactic core needle biopsy of nonpalpable breast lesions: initial experience with a promising technique. Arch Surg 1998; 133:366-372.
32. Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA Jr, Finkelstein SI, Shepard MJ. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology 1999; 210: 799-805.
33. Meyer JE, Smith DN, Lester SC, et al. Large-core needle biopsy of nonpalpable breast lesions. JAMA 1999; 281:1638-1641.
34. Jackman RJ, Nowels KW, Rodriguez-Soto J, et al. Stereotactic, automated, large core needle biopsy of non-palpable breast lesions: false negative and histologic underestimation rates after long term follow-up. Radiology 2000; 210:799-805.
35. Brenner RJ, Bassett LW, Fajardo LL, et al. Stereotactic core-needle breast biopsy: a multi-institutional prospective trial. Radiology 2001; 218:866-872.
36. Sickles EA, Parker SH. Appropriate role of core breast biopsy in the management of probably benign lesions. Radiology 1993; 188:315.
37. Logan-Young WW, Janus JA, Destounis SV, Hoffman NY. Appropriate role of core breast biopsy in the management of probably benign lesions. Radiology 1994; 190:313-314.
38. Sickles EA, Parker SH. Appropriate role of core breast biopsy in the management of probably benign lesions (reply). Radiology 1994; 190: 313-314.
39. Kopans DB. Caution on core (letter). Radiology 1994; 193:325-326.
40. Parker SH, Burbank F, Jackman RJ, et al. Response to "caution on core" (letter). Radiology 1994; 193:326-327.
41. Kopans DB. Reply (letter). Radiology 1994; 193:327-328.
42. Parker SH, Burbank F, Jackman RJ, et al. Final reply (letter). Radiology 1994; 193:328.
43. Berg WA. When is core breast biopsy of fine-needle aspiration not enough? Radiology 1996; 198:313-315.
44. Gundry KR, Berg WA. Treatment issues and core needle breast biopsy: clinical context. AJR Am J Roentgenol 1998; 171:41-49.
45. March DE, Raslavicus A, Coughlin BF, Klein SV, Makari-Judson G. Use of breast core biopsy in the United States: results of a national survey. AJR Am J Roentgenol 1997; 168:697-701.
46. Kimme-Smith C, Solberg T. Acceptance testing prone stereotactic breast biopsy units. Med Phys 1994; 21:1197-1201.
47. Pisano ED, Fajardo LL, Caudry DJ, et al. Fine-needle aspiration breast biopsy of nonpalpable lesions in a multicenter trial: results from the Radiologic Diagnostic Oncology Group V. Radiology 2001; 219:785-792.
48. Pisano ED, Fajardo LL, Tsimikas J, et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: the Radiologic Diagnostic Oncology Group 5 Study. Cancer 1998; 82:679-688.
49. Liberman L, Cohan MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxtic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol 1995; 164:1111-1113.
50. Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology 1997; 202:843-847.
51. Jackman RJ, Burbank F, Parker SH, et al. Atypical ductal hyperplasia diagnosed at sterotactic breast biopsy: improved reliability with 14-gauge, directional vacuum-assisted biopsy. Radiology 1997; 204:485-488.
52. Silverstein MJ, Cohlan BF, Gierson ED, et al. Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 1992; 28:630-634.
53. Lee CH, Egglin TK, Philpotts L, Mainiero MB, Tocino I. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. Radiology 1997; 202:849-854.
54. Lindfors KK, Rosenquist CJ. Needle core biopsy with mammography: a study of cost effectiveness. Radiology 1994; 190:217-222.
55. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22:1232-1239.
56. Rosen PP, Senie R, Schottenfeld D, Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg 1979; 189:377-382.
57. Simkovich AH, Sclafani LM, Masri M, Kinne DW. Role of contralateral breast biopsy in infiltrating lobular cancer. Surgery 1993; 114:555-557.
58. CMS Medicare Coverage Policy #CAG-0004ON. Percutaneous image-guided breast biopsy, December 7, 1999. Available at: http://www.cms.gov/coverage/8b3%2Djj2.asp].
59. Jackman RJ, Marzoni FA. Needle-localized breast biopsy: why do we fail? Radiology 1997; 204:677-684.
60. Handy RB, Fajardo LL, Innis CA, Witzke DB, Hunter TB. Patient perceptions of stereotaxic large-core breast biopsy. Acad Radiol 1996; 3:1007-1011.